Benzaquen, Michael Joseph

Up a level
Export as [feed] RSS
Group by: Date | Item Type | Refereed | No Grouping
Jump to: 2023 | 2022 | 2021 | 2020


Haykal, Diala; Cartier, Hugues; Benzaquen, Michael; Damiani, Giovanni; Habib, Sayed Meelad (2023). The growing importance of ultrasonography in cosmetic dermatology: An update after the 23rd IMCAS Annual World Congress (2022). Journal of cosmetic dermatology, 22(1), pp. 222-225. Blackwell Science 10.1111/jocd.15503


Moreau, T; Benzaquen, M; Gueissaz, F (2022). Erythema ab igne after using a virtual reality headset: a new phenomenon to know. Journal of the European Academy of Dermatology and Venereology : JEADV, 36(11), e932-e933. Wiley 10.1111/jdv.18371

Imstepf, Valentina A; Schlapbach, Christoph; Benzaquen, Michael; Feldmeyer, Laurence; Lipsker, Dan; Borradori, Luca (2022). Localized aseptic neutrophilic dermatoses of the extremities triggered by stasis and tissue damage: Two case reports of an unrecognized condition misdiagnosed as bacterial cellulitis. JAAD case reports, 28, pp. 14-17. Elsevier 10.1016/j.jdcr.2022.07.036

Bertschi, Nicole L; Steck, Oliver; Luther, Fabian; Bazzini, Cecilia; von Meyenn, Leonhard; Felser, Andrea; Keller, Irene; Friedli, Olivier; Freigang, Stefan; Begré, Nadja; Lamos, Cristina; Gabutti, Max Philip; Benzaquen, Michael; Laimer, Markus; Simon, Dagmar; Nuoffer, Jean-Marc; Schlapbach, Christoph (16 August 2022). PPAR-γ regulates the effector function of human TH9 cells by promoting glycolysis (bioRxiv). Cold Spring Harbor Laboratory 10.1101/2022.08.16.503972

Benzaquen, Michael; Munshi, Mohammad; Bossart, Simon; Feldmeyer, Laurence; Emelianov, Vladimir; Yawalkar, Nikhil; Cazzaniga, Simone; Heidemeyer, Kristine (2022). Long-Term Dose Optimization of Adalimumab via Dose Spacing in Patients with Psoriasis. bioengineering, 9(8) MPDI 10.3390/bioengineering9080387


Benzaquen, Michael; Fongue, Jessica; Pauly, Vanessa; Collet-Villette, Anne-Marie (2021). Laser-Assisted Hyaluronic Acid Delivery by Fractional Carbon Dioxide Laser in Facial Skin Remodeling: A Prospective Randomized Split-Face Study in France. Lasers in surgery and medicine, 53(9), pp. 1166-1172. Wiley 10.1002/lsm.23403

Juzot, C; Sibaud, V; Amatore, F; Mansard, S; Seta, V; Jeudy, G; Pham-Ledard, A; Benzaquen, M; Peuvrel, L; Le Corre, Y; Lesage, C; Viguier, M; Baroudjian, B; Dréno, B; Quéreux, G (2021). Clinical, biological and histological characteristics of bullous pemphigoid associated with anti-PD-1/PD-L1 therapy: A national retrospective study. Journal of the European Academy of Dermatology and Venereology : JEADV, 35(8), e511-e514. Wiley 10.1111/jdv.17253


de Daruvar, M; Benzaquen, M.; Berbis, P; Delaporte, E (2020). [Localised pretibial pemphigoid secondary to skin haematoma]. Annales de dermatologie et de vénéréologie, 147(12), pp. 905-906. Elsevier 10.1016/j.annder.2020.06.007

Delaunay, Pascal; Benzaquen, Michael; Berenger, Jean-Michel; Parola, Philippe (2020). Bed bug bites. Dermatologic therapy, 33(6), e14341. Wiley-Blackwell 10.1111/dth.14341

Barré, Mathilde; Delaporte, Emmanuel; Berbis, Philippe; Benzaquen, Michael (2020). Severe dermatomyositis revealing a thymic carcinoma: Did rituximab delay the diagnosis? Dermatologic therapy, 33(6), e14016. Wiley-Blackwell 10.1111/dth.14016

Benzaquen, Michael; Yawalkar, Nikhil; Feldmeyer, Laurence; Borradori, Luca; Schlapbach, Christoph (2020). Herpetiform aphthous ulcerations induced by secukinumab: Report of 2 cases. JAAD case reports, 6(10), pp. 1107-1109. Elsevier 10.1016/j.jdcr.2020.08.028

Benzaquen, Michael (2020). Update on the anti-programmed cell death-1 receptor antibodies in advanced cutaneous squamous-cell carcinoma. Dermatologic therapy, 33(3), e13325. Wiley-Blackwell 10.1111/dth.13325

Provide Feedback